(1.03%) 5 180.74 points
(0.46%) 38 852 points
(1.19%) 16 349 points
(0.50%) $78.87
(0.23%) $2.20
(0.12%) $2 334.00
(0.18%) $27.67
(0.19%) $966.70
(0.03%) $0.929
(0.04%) $10.83
(0.03%) $0.796
(-0.01%) $91.34
Live Chart Being Loaded With Signals
Astec LifeSciences Limited, together with its subsidiaries, manufactures, distributes, and sells agrochemicals active ingredients and pharmaceutical intermediates in India...
Stats | |
---|---|
今日成交量 | 62 813.00 |
平均成交量 | 78 859.00 |
市值 | 24.30B |
EPS | INR0 ( 2024-05-01 ) |
下一个收益日期 | ( INR0 ) 2024-07-25 |
Last Dividend | INR1.500 ( 2023-07-20 ) |
Next Dividend | INR0 ( N/A ) |
P/E | -47.67 |
ATR14 | INR1.799 (0.15%) |
音量 相关性
Astec LifeSciences 相关性
10 最正相关 | |
---|---|
ATUL.NS | 0.945 |
PFIZER.NS | 0.943 |
FINEORG.NS | 0.942 |
LALPATHLAB.NS | 0.942 |
BATAINDIA.NS | 0.939 |
ENIL.NS | 0.938 |
LAURUSLABS.NS | 0.938 |
HDFCAMC.NS | 0.937 |
INSECTICID.NS | 0.935 |
BIOCON.NS | 0.933 |
10 最负相关 | |
---|---|
JSL.NS | -0.935 |
ISMTLTD.NS | -0.924 |
JSLHISAR.NS | -0.915 |
JINDALSAW.NS | -0.909 |
DFMFOODS.NS | -0.906 |
4THDIM.NS | -0.9 |
NEWGEN.NS | -0.899 |
KIRLFER.NS | -0.898 |
OIL.NS | -0.897 |
LTGILTBEES.NS | -0.897 |
你知道吗?
相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1,其中-1表示完全负相关(一个变量增加,另一个变量减少),1表示完全正相关(一个变量增加,另一个变量也增加),0表示没有相关性(变量之间没有关系)。
相关性可用于分析任何两个变量之间的关系,而不仅仅是股票。它通常用于金融、经济学、心理学等领域。
Astec LifeSciences 相关性 - 货币/商品
Astec LifeSciences 财务报表
Annual | 2023 |
营收: | INR4.58B |
毛利润: | INR409.03M (8.93 %) |
EPS: | INR-23.93 |
FY | 2023 |
营收: | INR4.58B |
毛利润: | INR409.03M (8.93 %) |
EPS: | INR-23.93 |
FY | 2022 |
营收: | INR6.28B |
毛利润: | INR2.27B (36.12 %) |
EPS: | INR13.04 |
FY | 2022 |
营收: | INR6.77B |
毛利润: | INR2.86B (42.23 %) |
EPS: | INR45.87 |
Financial Reports:
No articles found.
Astec LifeSciences Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
INR1.500 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR1.500 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | INR1.000 | 2010-08-12 |
Last Dividend | INR1.500 | 2023-07-20 |
Next Dividend | INR0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 13 | -- |
Total Paid Out | INR15.50 | -- |
Avg. Dividend % Per Year | 0.08% | -- |
Score | 1.45 | -- |
Div. Sustainability Score | 2.33 | |
Div.Growth Potential Score | 2.92 | |
Div. Directional Score | 2.63 | -- |
Year | Amount | Yield |
---|---|---|
2010 | INR0 | 0.00% |
2011 | INR0 | 0.00% |
2012 | INR0 | 0.00% |
2013 | INR0 | 0.00% |
2014 | INR0 | 0.00% |
2015 | INR0 | 0.00% |
2016 | INR0 | 0.00% |
2017 | INR0 | 0.00% |
2018 | INR1.500 | 0.21% |
2019 | INR1.500 | 0.28% |
2020 | INR1.500 | 0.34% |
2021 | INR1.500 | 0.12% |
2022 | INR1.500 | 0.10% |
2023 | INR1.500 | 0.09% |
2024 | INR0 | 0.00% |
The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
RVNL.NS | Dividend Knight | 2023-09-20 | Annually | 6 | 3.08% | |
LSIL.NS | Dividend Junior | 2023-07-17 | Annually | 3 | 0.23% | |
GEOJITFSL.NS | Dividend Knight | 2023-06-30 | Annually | 20 | 2.79% | |
ARVIND.NS | Dividend Junior | 2023-07-21 | Sporadic | 20 | 0.59% | |
THEMISMED.NS | Dividend Junior | 2023-08-31 | Sporadic | 18 | 0.39% | |
ORIENTELEC.NS | Dividend Junior | 2023-07-26 | Semi-Annually | 7 | 0.41% | |
IRFC.NS | Dividend Junior | 2023-09-15 | Annually | 4 | 2.61% | |
CUB.NS | Dividend Junior | 2023-08-11 | Annually | 23 | 0.35% | |
SHRADHA.NS | Dividend Junior | 2023-07-06 | Sporadic | 6 | 0.99% | |
MAPMYINDIA.NS | Dividend Junior | 2023-08-25 | Annually | 3 | 0.13% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | -0.102 | 1.500 | -2.05 | -3.07 | [0 - 0.5] |
returnOnAssetsTTM | -0.0481 | 1.200 | -1.605 | -1.925 | [0 - 0.3] |
returnOnEquityTTM | -0.121 | 1.500 | -2.45 | -3.68 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 1.003 | 0.800 | 9.98 | 7.99 | [1 - 3] |
quickRatioTTM | 0.432 | 0.800 | -2.17 | -1.733 | [0.8 - 2.5] |
cashRatioTTM | 0.00612 | 1.500 | -1.077 | -1.616 | [0.2 - 2] |
debtRatioTTM | 0.507 | -1.500 | 1.557 | -2.34 | [0 - 0.6] |
interestCoverageTTM | -1.597 | 1.000 | -1.702 | -1.702 | [3 - 30] |
operatingCashFlowPerShareTTM | 16.04 | 2.00 | 4.65 | 9.31 | [0 - 30] |
freeCashFlowPerShareTTM | 6.14 | 2.00 | 6.93 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 1.337 | -1.500 | 4.65 | -6.98 | [0 - 2.5] |
grossProfitMarginTTM | 0.251 | 1.000 | 9.14 | 9.14 | [0.2 - 0.8] |
operatingProfitMarginTTM | -0.0879 | 1.000 | -3.76 | -3.76 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.0637 | 1.000 | -0.757 | -0.757 | [0.2 - 2] |
assetTurnoverTTM | 0.470 | 0.800 | -0.200 | -0.160 | [0.5 - 2] |
Total Score | 2.33 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | -52.29 | 1.000 | -5.38 | 0 | [1 - 100] |
returnOnEquityTTM | -0.121 | 2.50 | -1.578 | -3.68 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 6.14 | 2.00 | 7.95 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 0.120 | 1.500 | 7.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 16.04 | 2.00 | 4.65 | 9.31 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 0.731 | 1.500 | 8.46 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.0686 | 1.000 | -0.784 | 0 | [0.1 - 0.5] |
Total Score | 2.92 |
Astec LifeSciences
Astec LifeSciences Limited, together with its subsidiaries, manufactures, distributes, and sells agrochemicals active ingredients and pharmaceutical intermediates in India. It manufactures a range of fungicides, insecticides, herbicides, and intermediates, such as triazole fungicides, heterocyclic herbicides, sulfonyl urea herbicides, synthetic pyrethroids, alkyl and aryl magnesium halides, mixed metal halides, and silane derivatives; fluorinated aromatic amines, pyridine derivatives, aromatic carboxylic acids, benzyl alcohols, ketones and benzophenones, and heterocyclic mercaptans; fluorinated aromatic, aliphatic, and heterocyclic intermediates; heterocyclic mercaptans, thiopyrimidines, aromatic mercaptans, heterocyclic sulfonyl chlorides, heterocyclic sulphonamides, heterocyclic carbamates, thiourium salts, alkyl and aryl chloroformates, substituted pyrimidine diones, and pyrazolones; and substituted 1,2- and 1,3- pyrimidines. The company's products also comprise pyrazolyl aromatic ketones, morpholine derivatives, aromatic azo compounds, substituted triazines, imidate ethers, mesylated intermediates, substituted epoxides, ketals and bromo ketals, aromatic and aliphatic ethers, cyclopropyl ethers, cyclopropyl aldehydes and ketones, conjugated ketones, acetophenone derivatives, pinacolone derivatives, aliphatic and aromatic carboxylic acids, aliphatic and aromatic acid chlorides, halogenated and non-halogenated anhydrides, aliphatic alkenes, and halo alkanes; and aliphatic and aromatic brominated derivatives, cyanides, esters, carboxamides, amines, and alcohols and diols. It also exports its products. The company was incorporated in 1994 and is based in Mumbai, India. Astec LifeSciences Limited is a subsidiary of Godrej Agrovet Limited.
关于 实时信号
此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。
实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。